Luseogliflozin Monohydrate is a sodium-glucose cotransporter 2 (SGLT2) inhibitor used clinically in the management of type 2 diabetes mellitus by promoting the urinary excretion of glucose. This category… Read more
Luseogliflozin Monohydrate is a sodium-glucose cotransporter 2 (SGLT2) inhibitor used clinically in the management of type 2 diabetes mellitus by promoting the urinary excretion of glucose. This category provides essential chemical standards, including pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds, which are critical for rigorous analytical testing and quality control processes. Pharmaceutical laboratories rely on these high-quality reference materials to perform accurate impurity profiling and validate bioanalytical methods throughout drug development and manufacturing. By utilizing these precise standards, researchers can reliably monitor the purity of the active pharmaceutical ingredient and ensure compliance with regulatory standards. Whether for method validation, degradation studies, or routine stability testing, this collection supports the comprehensive characterization required to maintain safety and efficacy in therapeutic formulations of this SGLT2 inhibitor.